Overview

A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females

Status:
COMPLETED

Trial end date:
2024-06-07

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the drug interaction between povorcitinib and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.

Phase:

PHASE1

Details

Lead Sponsor:

Incyte Corporation

Treatments:

Ethinyl Estradiol-Norgestrel Combination